Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR07S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,900
Award facts
- Contract value 100% obligated
- $34,900.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $34.9K to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price, non-set-aside contract is performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.9M and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor and critical vendor for federal medical procurement. The company supplies pharmaceuticals and medical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's demonstrated capability to compete successfully in open, full-and-open competition for federal pharmaceutical contracts, combined with its significant IDC vehicle with DLA, positions it as a primary supplier of essential medical commodities to military treatment facilities and other federal health institutions.
Quick answers
Who was awarded contract SPE2DR26FR07S?
SPE2DR26FR07S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FR07S worth?
The government has obligated $34,900 on SPE2DR26FR07S.
Is contract SPE2DR26FR07S an order under another contract?
Yes. SPE2DR26FR07S is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR07S competed?
The extent of competition for SPE2DR26FR07S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award